BioCentury
ARTICLE | Finance

Silicon Twist

Why investors in Twist's series B think silicon will speed up gene synthesis

June 2, 2014 7:00 AM UTC

Investors in Twist Bioscience Corp.'s $26 million series B round expect the company's 10,000-well silicon platform will enable faster, cheaper and more accurate DNA synthesis than traditional 96-well plastic plates.

New investor Tao Invest led last week's round. Fellow new investors Applied Materials Inc.(NASDAQ:AMAT) and NanoDimension and existing investors Arch Venture Partners; Paladin Capital Group; Asset Management; and Yuri Milner joined the round...